IFN therapy has been reported to induce hypertrophy of the septal and posterior wall of the left ventricle days after the onset of treatment.42 There is a report of the development of fatal cardiomyopathy due to IFN therapy in an HCV-infected patient.43 Here, IFNA1 is linked to cardiomyopathy.